CMV Viremia
13 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| CMV Infection and Immune Intervention After Transplantation (NCT04320303) | Peking University People's Hospital | 2020-03-23 |
| Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells (NCT03798301) | University of Wisconsin, Madison | 2020-02-06 |
| The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human (NCT04298502) | Peking University People's Hospital | 2020-01-01 |
| Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients (NCT04018261) | Banc de Sang i Teixits | 2019-07-04 |
| Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients (NCT01329185) | University of Minnesota | 2011-06-01 |
| Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease (NCT03010332) | Atara Biotherapeutics |
Track CMV Viremia automatically
Every clearance here is in the API, with alerts when new ones post.